Annual Revenue
$13.80 M
-$2.22 M-13.87%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual revenue is $13.80 million, with the most recent change of -$2.22 million (-13.87%) on December 31, 2023.
- During the last 3 years, VVOS annual revenue has risen by +$735.00 thousand (+5.63%).
- VVOS annual revenue is now -18.26% below its all-time high of $16.89 million, reached on December 31, 2021.
Performance
VVOS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$3.86 M
-$194.00 K-4.79%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly revenue is $3.86 million, with the most recent change of -$194.00 thousand (-4.79%) on September 30, 2024.
- Over the past year, VVOS quarterly revenue has stayed the same.
- VVOS quarterly revenue is now -15.09% below its all-time high of $4.55 million, reached on September 30, 2021.
Performance
VVOS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$14.58 M
+$559.00 K+3.99%
September 30, 2024
Summary
- As of February 8, 2025, VVOS TTM revenue is $14.58 million, with the most recent change of +$559.00 thousand (+3.99%) on September 30, 2024.
- Over the past year, VVOS TTM revenue has stayed the same.
- VVOS TTM revenue is now -14.64% below its all-time high of $17.08 million, reached on March 31, 2022.
Performance
VVOS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
VVOS Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -13.9% | 0.0% | 0.0% |
3 y3 years | +5.6% | -15.1% | -7.7% |
5 y5 years | +263.9% | +11.9% | +9.5% |
VVOS Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -18.3% | at low | -12.2% | +18.8% | -14.6% | +9.1% |
5 y | 5-year | -18.3% | +21.1% | -15.1% | +26.3% | -14.6% | +128.8% |
alltime | all time | -18.3% | +263.9% | -15.1% | +26.3% | -14.6% | +339.7% |
Vivos Therapeutics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $3.86 M(-4.8%) | $14.58 M(+4.0%) |
Jun 2024 | - | $4.05 M(+18.6%) | $14.02 M(+4.9%) |
Mar 2024 | - | $3.42 M(+5.3%) | $13.36 M(-3.2%) |
Dec 2023 | $13.80 M(-13.9%) | $3.25 M(-1.6%) | $13.80 M(-4.8%) |
Sep 2023 | - | $3.30 M(-2.8%) | $14.50 M(-6.1%) |
Jun 2023 | - | $3.40 M(-12.0%) | $15.45 M(-4.9%) |
Mar 2023 | - | $3.86 M(-2.4%) | $16.24 M(+1.3%) |
Dec 2022 | $16.02 M(-5.1%) | $3.95 M(-7.0%) | $16.02 M(-2.7%) |
Sep 2022 | - | $4.25 M(+1.5%) | $16.47 M(-1.8%) |
Jun 2022 | - | $4.18 M(+14.8%) | $16.77 M(-1.8%) |
Mar 2022 | - | $3.64 M(-17.1%) | $17.08 M(+1.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $16.89 M(+29.2%) | $4.39 M(-3.3%) | $16.89 M(+6.9%) |
Sep 2021 | - | $4.55 M(+1.1%) | $15.80 M(+8.6%) |
Jun 2021 | - | $4.50 M(+30.4%) | $14.54 M(+9.2%) |
Mar 2021 | - | $3.45 M(+4.3%) | $13.32 M(+1.9%) |
Dec 2020 | $13.07 M(+14.7%) | $3.31 M(+0.5%) | $13.07 M(+2.0%) |
Sep 2020 | - | $3.29 M(+0.6%) | $12.81 M(-0.2%) |
Jun 2020 | - | $3.27 M(+2.3%) | $12.84 M(+34.2%) |
Mar 2020 | - | $3.20 M(+4.6%) | $9.57 M(+50.2%) |
Dec 2019 | $11.39 M(+200.4%) | $3.06 M(-7.8%) | $6.37 M(+92.2%) |
Sep 2019 | - | $3.32 M | $3.32 M |
Dec 2018 | $3.79 M | - | - |
FAQ
- What is Vivos Therapeutics annual revenue?
- What is the all time high annual revenue for Vivos Therapeutics?
- What is Vivos Therapeutics annual revenue year-on-year change?
- What is Vivos Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly revenue year-on-year change?
- What is Vivos Therapeutics TTM revenue?
- What is the all time high TTM revenue for Vivos Therapeutics?
- What is Vivos Therapeutics TTM revenue year-on-year change?
What is Vivos Therapeutics annual revenue?
The current annual revenue of VVOS is $13.80 M
What is the all time high annual revenue for Vivos Therapeutics?
Vivos Therapeutics all-time high annual revenue is $16.89 M
What is Vivos Therapeutics annual revenue year-on-year change?
Over the past year, VVOS annual revenue has changed by -$2.22 M (-13.87%)
What is Vivos Therapeutics quarterly revenue?
The current quarterly revenue of VVOS is $3.86 M
What is the all time high quarterly revenue for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly revenue is $4.55 M
What is Vivos Therapeutics quarterly revenue year-on-year change?
Over the past year, VVOS quarterly revenue has changed by $0.00 (0.00%)
What is Vivos Therapeutics TTM revenue?
The current TTM revenue of VVOS is $14.58 M
What is the all time high TTM revenue for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM revenue is $17.08 M
What is Vivos Therapeutics TTM revenue year-on-year change?
Over the past year, VVOS TTM revenue has changed by $0.00 (0.00%)